Table 3.
Hemodynamic parameters measured during three stages of the liver transplantation in the study groups. Values are mean±SD
| Variable |
Restricted
Crystalloid fluid group (n=34) |
Non-restricted
Crystalloid fluid group (n=33) |
p value |
|---|---|---|---|
| Baseline | |||
| MAP* (mm Hg) | 70.6± 3.9 | 70.0±2.9 | 0.20 |
| Heart rate (beats/min) | 112.5±5.9 | 108.8±6.8 | 0.43 |
| CVP† (mm Hg) | 7.9±2.7 | 7.0±3.4 | 0.56 |
| Hepatectomy phase | |||
| MAP(mm Hg) | 72.5±6.9 | 61.1±2.8 | 0.01 |
| Hear rate (beats/min) | 87.6± 3.7 | 90.8±1.9 | 0.03 |
| CVP (mm Hg) ‡CO (L/min) |
8.2±2.8 6.7±0.6 |
13.9±2.9 6.6±1.0 |
0.001 0.38 |
| An-hepatic phase | |||
| MAP (mmHg) | 67.3±2.6 | 55.8±3.7 | 0.001 |
| Hear rate (beats/min) | 90.8±2.0 | 109.2 ±2.7 | 0.01 |
| CVP (mm Hg) CO (L/min) |
8.7±1.5 4.3±0.05 |
12.8±3.0 5.0±0.05 |
0.02 0.08 |
| Neo-hepatic phase | |||
| MAP (mm Hg) | 75.78 ±3.01 | 61.1±1.1 | 0.001 |
| Hear rate (beats/min) | 84.65±1.98 | 81.9±3.1 | 0.24 |
| CVP (mm Hg) CO (L/min) |
8.51±1.02 5.43±0.78 |
15.0±2.1 5.0±0.8 |
0.01 0.71 |
*
MAP: Mean arterial pressure
†
CVP: Central venous pressure
‡
CO: Cardiac output